Skip to main content
V-Lab
V-Lab

Chemomab Therapeutics Ltd Asymmetric ILLIQ Liquidity Analysis

High-persistence model: shocks decay very slowly, so the theoretical long-run value may not be practically meaningful

Illiquidity prediction for Wednesday, September 30th, 2026

1 Day

243,368.80

decreased by 27,786.00

1 Week

222,846.82

decreased by 48,307.98

1 Month

153,864.95

decreased by 117,289.85

Analysis last updated: Tuesday, September 29, 2026 at 09:10 PM UTC

Press Delete or Backspace to remove this series.
Date Range:

from

09/29/2024

to

09/29/2026

6M ·

1Y ·

2Y ·

5Y ·

All

graph of Chemomab Therapeutics Ltd ILLIQ-AMEM

News Impact Curve

How returns affect tomorrow's illiquidity

Illiquidity Forecast

How illiquidity evolves over time

Parameter Estimates

Feb 12, 2019 to Sep 25, 2026

Model Insight

Estimated persistence of 1.000 is at or above 1 (non-stationary): illiquidity shocks do not decay and the long-run level is undefined, so long-horizon forecasts should be treated with caution.

μ

ILLIQ-AMEM Model

Tap to view equation

High persistence: persistence 1.000 ≥ 1, shocks do not decay
ParamValuet-stat
ωconst0.0000
0.00
αARCH0.0501
1.03
βGARCH0.8790
39.53***
γleverage0.1418
1.92*

1.000

Persistence

-

Half-life
μ

ILLIQ-AMEM Model

Tap to view equation

ParameterValuet-statistic
ω

const

Unconditional variance weight

0.0000
0.00
α

ARCH

Response to squared shocks

0.0501
1.03
β

GARCH

Volatility persistence

0.8790
39.53***
γ

leverage

Additional response to negative shocks

0.1418
1.92*

Persistence:

1.000

Half-life:

-